**Question:** RxofDI-

A. Beta-blocker
B. Angiotensin-converting enzyme (ACE) inhibitor
C. Angiotensin II receptor blocker (ARB)
D. Calcium channel blocker

**Core Concept:** The RxofDI- acronym is used to memorize the names of commonly prescribed drugs for controlling blood pressure in a step-wise manner based on the underlying pathophysiology. In this case, the acronym stands for:

1. **Beta-blocker (Option A):** This class of drugs is used to target the sympathetic nervous system, which plays a significant role in regulating blood pressure. Beta-blockers inhibit the activity of beta-adrenergic receptors, thereby reducing the effects of catecholamines (e.g., adrenaline) on the heart and blood vessels, ultimately leading to a decrease in cardiac output and peripheral vascular resistance.

2. **Angiotensin-converting enzyme (ACE) inhibitor (Option B):** ACE inhibitors are medications primarily used to treat high blood pressure by blocking the conversion of angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor, and its inhibition leads to vasodilation and decreased blood pressure.

3. **Angiotensin II receptor blocker (Option C):** ARBs act by blocking the effects of angiotensin II at its receptors, thus preventing the vasoconstrictor and aldosterone-releasing effects of angiotensin II, leading to vasodilation and decreased blood pressure.

4. **Calcium channel blocker (Option D):** Calcium channel blockers work by inhibiting the influx of calcium ions into smooth muscle cells of the arterial wall, leading to vasodilation and decreased cardiac contractility, which results in a reduction in blood pressure.

**Why the Correct Answer is Right:**

The correct answer (Options B, C, and D) target different aspects of the renin-angiotensin-aldosterone system (RAAS) to reduce blood pressure in a step-wise manner.

**Why Each Wrong Option is Incorrect:**

Option A (Beta-blocker) is incorrect because it primarily targets the sympathetic nervous system, which has a less direct effect on blood pressure regulation compared to the RAAS system. These RAAS inhibitors have a more significant impact on blood pressure control.

In summary, these medications (ACE inhibitors, ARBs, and calcium channel blockers) effectively reduce blood pressure by blocking the actions of angiotensin II, a potent vasoconstrictor and aldosterone-releasing hormone, thereby promoting vasodilation and decreased cardiac contractility.